• KOSPI

    2,536.60 34.49 (+1.38%)
  • KOSDAQ

    894.43 21.34 (+2.44%)
  • Dollar/Won

    1,070.20 0.10 (+0.01%)
증권시황 정보 열기

Dongwha Pharm promotes heir-apparent for fourth-generation succession

2018.01.10 14:49:30 | 2018.01.10 16:29:52
  • print
  • email
  • facebook
  • twitter
  • share
Even for the son of the boss in a country where family-run business is common, the case with the heir apparent at Dongwha Pharm Co., Korea’s oldest drug maker, has been exceptional as he jumped to the senior executive position in just four years of joining the company.

The 121-year-old pharmaceutical company announced Tuesday that 34-year-old Yoon In-ho, eldest son of chairman Yoon Doh-joon, has been promoted to a vice president.

The younger Yoon studied economics at the University of Wisconsin-Madison and joined the company in 2013. He doubles as the CEO of Dongwha G&P, a bottling company with the largest stake of 15.22 percent in Dongwha Pharm.

Shares of Dongwha Pharm Wednesday ended 0.72 percent up at 9,840 won from the previous session.

By Kim Myung-hwan and Lee Ha-yeon

[ⓒ Pulse by Maeil Business News Korea & mk.co.kr, All rights reserved]

ad

weather

  • Seoul Tue 23 January 2018
  • TUE

    -15.0℃

Get Newsletters